Identifying specific proteins in cancer tissues and fluids
Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids
This study is looking at special proteins in cancer that might help us understand how the disease grows and could lead to better ways to diagnose it, using samples from patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical University of South Carolina NIH-funded |
| Lab location | 1 site (Charleston, United States) |
| Project ID | NIH-10795043 on NIH RePORTER |
What this research studies
This research focuses on the identification and isolation of glycoproteins that are altered in cancer. By using advanced imaging techniques and specific chemical reagents, the study aims to analyze tumor tissues, biofluids, and cancer cell lines to better understand the role of these proteins in cancer progression. Patients' samples will be examined to identify specific glycoproteins associated with their tumors, which could lead to improved diagnostic methods. The research employs innovative methodologies to enhance the detection of these important biomarkers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who are undergoing treatment or have provided tissue samples.
Not a fit: Patients with non-cancerous conditions or those who do not have available tissue or biofluid samples may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnostics and targeted therapies for patients.
How similar studies have performed: Previous research has shown success in identifying cancer biomarkers using similar glycoprotein isolation techniques, indicating a promising approach.
Where this research is happening
Charleston, United States
- Medical University of South Carolina — Charleston, United States (Active)
Researchers
- Principal investigator: Drake, Richard R. — Medical University of South Carolina
- Study coordinator: Drake, Richard R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.